Changes in strategies for optimal antibacterial therapy in cystic fibrosis

International Journal of Antimicrobial Agents

Volumn 17, Issue 2, 2001, Pages 93-96

  Ratjen, F ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Antibiotic therapy; Cystic fibrosis; Pseudomonas aeruginosa; Staphylcoccus aureus

Indexed keywords

AMINOGLYCOSIDE; ANTIBIOTIC AGENT; BRAMYCIN; CEFALEXIN; CEPHALOSPORIN; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; FLUCLOXACILLIN; FOSFOMYCIN; MEROPENEM; PENICILLIN G; TICARCILLIN; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIMICROBIAL THERAPY; CYSTIC FIBROSIS; HUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CYSTIC FIBROSIS; DRUG THERAPY, COMBINATION; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0035145159     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00333-2     Document Type: Review

References (32)

1. The changing epidemiology of cystic fibrosis
2. Microbiology of lung infections in cystic fibrosis patients
3. Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients
4. Lower respiratory infection and inflammation in newly diagnosed cystic fibrosis
5. Fractional analysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function
6. BALF PCR and ELISA identification of nonculturable Pseudomonas aeruginosa in infants and toddlers with cystic fibrosis
7. Antimicrobial chemotherapy in cystic fibrosis
8. Antibiotic treatment of Staph. aureus infection in cystic fibrosis
9. Antibiotic prescribing practice in the UK and Eire
10. Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period
11. Pulmonary function in infants with cystic fibrosis; the effect of antibiotic treatment
12. To Keflex or not to Keflex: Long term antibiotics in CF
13. Association between prophylactic antibiotic usage and early onset of Pseudomonas aeruginosa
14. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to infections
15. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid
16. Bioactivity of gentamicin in purulent sputum from patients with cystic fibrosis or bronchiectasis: comparison with activity in sputum
17. Antibiotic activity in sputum
18. Protease of Pseudomonas aeruginosa in cystic fibrosis
19. Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis
20. Treatment of Pseudomonas colonisation in cystic fibrosis
21. Nebulised colomycin for early Pseudomonas colonisation in cystic fibrosis
22. Prevention of chronic Pseudomonas aeruginosa colonisation by early treatment
23. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis
24. Placebo-controlled double-blind randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonisation in cystic fibrosis
25. Long-term survival and nutritional data in patients with cystic fibrosis treated in a Danish centre
26. Long-term tobramycin inhalation in cystic fibrosis
27. Colistin inhalation therapy in cystic fibrosis patients with chronic P. aeruginosa infection
28. Safety and efficacy of tobramycin solution for inhalation in patients with cystic fibrosis. The results of 2 phases placebo controlled trials
29. In vitro activities of designed antimicrobial peptides against multidrug-resistant cystic fibrosis pathogens